https://doi.org/10.1200/jco.2015.65.2289
C
Catherine Van Poznak
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
240
Papers
14.3K
Citations
49
h-index
123
i10-index
Catherine Van Poznak is an academic researcher from University of Michigan–Ann Arbor. The author has contributed to research in topics: Bone health and treatments & Cancer Diagnosis and Treatment & Cancer Treatment and Pharmacology. The author has an h-index of 49, co-authored 204 publications.
ORCID: 0000-0001-5523-6908Papers by this author
worksUse of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
2016 · Journal of Clinical Oncology · 810 citations
Bone health in cancer: ESMO Clinical Practice Guidelines
2020 · Annals of Oncology · 492 citations
https://doi.org/10.1016/j.annonc.2020.07.019
Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline
2019 · Journal of Clinical Oncology · 391 citations
https://doi.org/10.1200/jco.19.01186
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update—Integration of Results From TAILORx
2019 · Journal of Clinical Oncology · 229 citations
https://doi.org/10.1200/jco.19.00945
Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases
2016 · Journal of Clinical Oncology · 167 citations
https://doi.org/10.1200/jco.2015.63.0343
Hypocalcaemia in patients with metastatic bone disease treated with denosumab
2015 · European Journal of Cancer · 144 citations
https://doi.org/10.1016/j.ejca.2015.05.016
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat